Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial
- PMID: 39014207
- PMCID: PMC11544297
- DOI: 10.1038/s41433-024-03232-9
Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial
Conflict of interest statement
The author declares no competing interests.
References
-
- Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122: 564–72. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15078675 [Accessed April 22, 2015]. - PubMed
-
- Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120: 844–51. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23332590 [Accessed June 21, 2015]. - PMC - PubMed
LinkOut - more resources
Full Text Sources
